尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Appelhans Dannielle. Insider active across 2 companies, notably Rubius Therapeutics, Inc.. Cumulatively, 6 reports have been logged. Split: 2 buys · 1 sell. Total volume traded: €19k. Activity tracked since 24 February 2023. The latest transaction was disclosed on 8 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Appelhans Dannielle is a declarant linked to Generation Bio Co., where she is Director, and to Rubius Therapeutics, Inc., where she is CEO and President. She has 6 filings in total, and, across the sampled recent filings, buys amount to EUR 17606 and sells to EUR 1248, from 2022-08-12 to 2026-02-09.